StonvexLoading…
StonvexCore line items from OPY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $399.37M | $1.42B | $1.01B | $637.55M |
Operating Income | $-27.00M | $211.19M | $105.22M | $73.59M |
Net Income | $-20.58M | $148.40M | $74.04M | $52.33M |
EPS (Diluted) | $-1.93 | $13.04 | $6.53 | $4.63 |
Total Assets | $3.82B | $3.72B | $3.82B | $3.69B |
Total Liabilities | $2.85B | $2.73B | $2.90B | $2.79B |
Cash & Equivalents | $34.60M | $38.41M | $38.29M | $37.62M |
Free Cash Flow OCF − CapEx | $-189.98M | $183.56M | $7.74M | $-54.48M |
Shares Outstanding | 10.64M | 11.38M | 11.35M | 11.31M |